ExploreWatchlistsPricing
  1. JP-listed companies
  2. StemCell Institute Inc.
  3. Financials
  4. Pretax margin (%)

StemCell Institute Inc. (7096)

Market cap
¥6.9B
P/E ratio
65.3x
Stemcell Research Institute stores umbilical cord blood and tissue for expecting families, preserving stem cells for potential future medical treatments.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 20267.7-51.76%
Mar 31, 202516-4.84%
Mar 31, 202416.8+17.09%
Mar 31, 202314.4+20.41%
Mar 31, 202211.9+81.95%
Mar 31, 20216.6-71.27%
Mar 31, 202022.8+21.33%
Mar 31, 201918.8+45.70%
Mar 31, 201812.9-35.63%
Mar 31, 201720.1-19.22%
Mar 31, 201624.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat